DCAL — Dishman Carbogen Amcis Share News
0.000.00%
Last trade - 00:00- IN₹21.37bn
- IN₹41.82bn
- IN₹29.32bn
Brief: Dishman Carbogen Amcis June-Quarter Consol Net Profit 40.1 Million Rupees
Brief: Dishman Carbogen Amcis Reports Dec-Quarter Consol Net Profit 353.8 Mln Rupees
Brief: Dishman Carbogen Amcis Announces Results From Partnership With Boston University School Of Medicine On Clinical Research Study
Brief: Dishman Carbogen Amcis Unit Successfully Completes FDA Inspection Of Its Facility In Aarau, Switzerland
Brief: Dishman Carbogen Amcis June-Quarter Loss After Tax Narrows
Brief: Dishman Carbogen Amcis- Adimans Technologies Proposes To Sell 6.9 Million Shares Of Co
Brief: Dishman Carbogen Amcis Sept-Qtr Consol Net PAT Falls
Brief: Dishman Carbogen Amcis Approves Capex Plans At Units In Switzerland, France
Brief: India's Dishman Carbogen Amcis Dec Quarter Consol Profit Falls
Approved Buy-Back Of Shares Of Company
Brief: Dishman Carbogen To Hold Investor Call Later On Thursday
Brief: Dishman Carbogen Amcis Updates on Income-Tax Department Search At Premises
Brief: India's Dishman Carbogen Amcis Sept Quarter Consol Net Profit Falls
Brief: Dishman Carbogen Amcis To Buy Dishman Biotech For 45 Mln Rupees
Brief: India's Dishman Carbogen Amcis March-Qtr Profit Rises
Brief: Dishman Carbogen Amcis Janmejay R. Vyas To Step Down As MD
Brief: India's Dishman Carbogen Amcis Says U.S FDA Completes Inspection At Naroda Facility
Brief: Dishman Carbogen Amcis Gets EIR From U.S. FDA For Bavla Facility
Brief: India's Dishman Carbogen Amcis Dec-Qtr Consol Net PAT Rises